US 11,654,216 B2
Self-expanding devices and methods therefor
Donald J. Eaton, Los Altos, CA (US); Bin Huang, Pleasanton, CA (US); Anthony J. Abbate, Santa Clara, CA (US); Gail M. Zaler, Milpitas, CA (US); and David C. Gale, Kennesaw, GA (US)
Assigned to Intersect ENT, Inc., Menlo Park, CA (US)
Filed by Intersect ENT, Inc., Menlo Park, CA (US)
Filed on Dec. 26, 2019, as Appl. No. 16/727,345.
Application 16/727,345 is a continuation of application No. 16/588,294, filed on Sep. 30, 2019, granted, now 11,497,835.
Application 16/588,294 is a continuation of application No. 16/021,659, filed on Jun. 28, 2018, granted, now 10,471,185, issued on Nov. 12, 2019.
Application 16/021,659 is a continuation of application No. 14/081,974, filed on Nov. 15, 2013, granted, now 10,010,651, issued on Jul. 3, 2018.
Application 14/081,974 is a continuation of application No. 12/334,373, filed on Dec. 12, 2008, granted, now 8,585,730, issued on Nov. 19, 2013.
Claims priority of provisional application 61/058,803, filed on Jun. 4, 2008.
Claims priority of provisional application 61/014,653, filed on Dec. 18, 2007.
Prior Publication US 2020/0206391 A1, Jul. 2, 2020
Int. Cl. A61L 31/02 (2006.01); A61F 2/86 (2013.01); A61F 2/95 (2013.01); A61F 5/08 (2006.01); A61L 31/14 (2006.01); A61B 17/24 (2006.01); A61B 17/34 (2006.01); A61K 9/70 (2006.01); A61F 2/89 (2013.01); A61L 31/16 (2006.01); A61F 2/04 (2013.01); A61F 2/18 (2006.01); A61L 31/10 (2006.01); A61F 2/82 (2013.01); A61M 29/00 (2006.01); A61F 2/915 (2013.01)
CPC A61L 31/022 (2013.01) [A61B 17/24 (2013.01); A61B 17/3468 (2013.01); A61B 17/3478 (2013.01); A61F 2/04 (2013.01); A61F 2/18 (2013.01); A61F 2/82 (2013.01); A61F 2/86 (2013.01); A61F 2/89 (2013.01); A61F 2/95 (2013.01); A61F 5/08 (2013.01); A61K 9/70 (2013.01); A61L 31/10 (2013.01); A61L 31/148 (2013.01); A61L 31/16 (2013.01); A61M 29/00 (2013.01); A61B 2017/3454 (2013.01); A61F 2/186 (2013.01); A61F 2/9522 (2020.05); A61F 2/9524 (2020.05); A61F 2002/048 (2013.01); A61F 2002/91508 (2013.01); A61F 2210/0004 (2013.01); A61F 2210/0076 (2013.01); A61F 2220/005 (2013.01); A61F 2220/0058 (2013.01); A61F 2230/0091 (2013.01); A61F 2240/001 (2013.01); A61F 2250/003 (2013.01); A61F 2250/006 (2013.01); A61F 2250/0067 (2013.01)] 19 Claims
OG exemplary drawing
 
1. A method of treating one or more urinary conditions in a patient, the method comprising:
advancing a delivery device to a target tissue in a urethra, a ureter, or a bladder in the patient, where the delivery device comprises a flexible member with an expandable balloon arranged thereon, the expandable balloon being configured to expand from a first compressed configuration to a second expanded configuration, and where at least a portion of the delivery device has a drug-eluting layer comprising one or more drugs;
positioning the expandable balloon at the target tissue with the delivery device;
allowing release of one or more drugs from the drug-eluting layer to the target tissue;
expanding the expandable balloon from the first compressed configuration to the second expanded configuration to contact the target tissue;
detaching the expandable balloon from the flexible member after expanding the expandable balloon; and
withdrawing the flexible member after detaching the expandable balloon, thereby leaving the expandable balloon positioned at the target tissue in the second expanded configuration.